Concerns raised over ARI staffing changes


Orkney MSP Liam McArthur has made a cross party plea to NHS Grampian to address concerns about staffing and capacity at Aberdeen Royal Infirmary’s skull based clinic. 

Mr McArthur has recently been informed, along with a number of MSPs, that changes to staffing at the skull based clinic has meant patients with acoustic neuromas and pituitary tumours has not been seen at Aberdeen Royal Infirmary over the last two months.

Despite assurances from NHS Grampian, there have been reports of uncertainty around MRI and other appointments as a result of staff changes.

In a joint letter with Liam Kerr MSP to NHS Grampian Chief Executive, the MSP’s called for action to help address “anxiety among patients and their families.”

Commenting, Liam McArthur MSP said:

“Over recent years, a great deal of money has been raised to help deliver improvements to Aberdeen Royal Infirmary’s Neurology Ward. Orkney has led the way in these efforts, which have made a real difference to making life better for those affected by brain trauma.

“While I look forward to meeting NHS Grampian’s Chief Executive later this year to discuss the planned refurbishment of the ARI neuro ward, I am concerned to hear of staffing changes that appear to be putting pressure on services. The recent departure of key staff has caused anxiety amongst patients and their families, unsure what the implications might be.

“Already there are suggestions that MRI appointments are being delayed and concerns are being raised about some treatment having to be delivered further south. It is vital, therefore, that NHS Grampian provide urgent reassurances to patients that a succession plan is in place. Like Friends of the Neuro Ward, I want to see ARI continue to provide the excellent care and treatment that it has to date.”

Orkney’s MSP is due to meet NHS Grampian’s Chief Executive Malcolm Wright, 'Friends of the Neuro Ward ARI’ and others in Aberdeen to discuss the planned refurbishment of the ward on 28th October.

ENDS.


Share this post on social media:

Sign in with Facebook, Twitter or Email.